Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00823706
Other study ID # 122/08
Secondary ID
Status Recruiting
Phase N/A
First received January 15, 2009
Last updated April 4, 2011
Start date January 2009

Study information

Verified date January 2009
Source Assaf-Harofeh Medical Center
Contact yaniv barkana, md
Phone 97289779358
Email yanivbarkana@gmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The primary purpose of this study is to assess the prevalence of asymptomatic chronic angle closure in high risk Caucasian individuals, namely those with hyperopia. A secondary purpose is to assess whether specific demographic or ocular-anatomic parameters in this population are associated with a higher risk for angle closure.


Description:

Caucasian subjects aged > 40 years with hyperopia will undergo complete eye examination including subjective refraction and gonioscopy. In addition we will measure axial length, anterior chamber depth and lens thickness using ultrasound biometry.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Age greater than 40 years

- Hyperopia greater then +1.00 D spherical equivalent

Exclusion Criteria:

- Any identifiable eye disease or previous eye surgery that can affect the anatomy of the irido-corneal angle

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
Israel Assaf Harofe Medical Center Ophthalmology Department Zerifin

Sponsors (1)

Lead Sponsor Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary prevalence of chronic angle closure in Caucasian hyperopes 1 year No
Secondary relative risk for chronic angle closure measured for demographic and ocular-anatomic parameters 1 year No
See also
  Status Clinical Trial Phase
Completed NCT00452998 - Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study N/A
Active, not recruiting NCT01742819 - Advanced Glaucoma Progression Study